Pages that link to "Q81339934"

The following pages link to Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria (Q81339934):

Displaying 43 items.

• Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study (Q33397272) (← links)
• Have we made progress in the management of chronic graft-vs-host disease? (Q34644980) (← links)
• How we treat chronic graft-versus-host disease (Q35004923) (← links)
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report (Q35085226) (← links)
• Classic and overlap chronic graft-versus-host disease (cGVHD) is associated with superior outcome after extracorporeal photopheresis (ECP) (Q35174524) (← links)
• Prognostic Implications of the NIH Consensus Criteria in Children with Chronic Graft-versus-Host Disease (Q35176287) (← links)
• Center for International Blood and Marrow Transplant Research chronic graft-versus-host disease risk score predicts mortality in an independent validation cohort (Q35177449) (← links)
• Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria (Q35483810) (← links)
• The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality (Q35528671) (← links)
• A multicenter feasibility study of chronic graft-versus-host disease according to the National Institute of Health criteria: efforts to establish a Brazil-Seattle consortium as a platform for future collaboration in clinical trials (Q35748144) (← links)
• Overlap subtype of chronic graft-versus-host disease is associated with an adverse prognosis, functional impairment, and inferior patient-reported outcomes: a Chronic Graft-versus-Host Disease Consortium study (Q35794478) (← links)
• Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease (Q35800856) (← links)
• Evaluation of prognostic factors among patients with chronic graft-versus-host disease. (Q36133013) (← links)
• Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials (Q36540762) (← links)
• Understanding chronic GVHD from different angles (Q36551588) (← links)
• Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation (Q36678637) (← links)
• Prognostic factors of survival time after hematopoietic stem cell transplant in acute lymphoblastic leukemia patients: Cox proportional hazard versus accelerated failure time models (Q37032432) (← links)
• Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation (Q37041729) (← links)
• Characteristics of chronic GVHD after cord blood transplantation (Q37227600) (← links)
• Confounding factors affecting the National Institutes of Health (NIH) chronic Graft-Versus-Host Disease Organ-Specific Score and global severity (Q37313795) (← links)
• Skin response using NIH consensus criteria vs Hopkins scale in a phase II study for steroid-refractory chronic GVHD. (Q37476701) (← links)
• Analysis of gastrointestinal and hepatic chronic graft-versus-host [corrected] disease manifestations on major outcomes: a chronic graft-versus-host [corrected] disease consortium study (Q37495327) (← links)
• Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force. (Q37626094) (← links)
• Investigator feedback about the 2005 NIH diagnostic and scoring criteria for chronic GVHD. (Q37684622) (← links)
• Diagnosis and Staging of Chronic Graft-versus-Host Disease in the Clinical Practice (Q37778478) (← links)
• Graft-vs-Host Disease following Allogeneic Hematopoietic Cell Transplantation (Q37942818) (← links)
• Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria (Q38000900) (← links)
• Long-term follow-up of informal caregivers after allo-SCT: a systematic review (Q38021619) (← links)
• Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead (Q38573015) (← links)
• Evolving concepts in prognostic scoring of chronic GvHD. (Q38739174) (← links)
• Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors (Q39393617) (← links)
• Validation of NIH consensus criteria for diagnosis and severity-grading of chronic graft-versus-host disease (Q39474559) (← links)
• Clinical significance of subcategory and severity of chronic graft-versus-host disease evaluated by National Institutes of Health consensus criteria. (Q39763917) (← links)
• Reevaluation of the National Institutes of Health criteria for classification and scoring of chronic GVHD. (Q44772306) (← links)
• GVHD after unrelated cord blood transplant in children: characteristics, severity, risk factors and influence on outcome (Q47584995) (← links)
• New classification of chronic GVHD: added clarity from the consensus diagnoses. (Q53453729) (← links)
• Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells. (Q55467320) (← links)
• Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults (Q57918596) (← links)
• The graft-versus-leukemia effect is mainly restricted to NIH-defined chronic graft-versus-host disease after reduced intensity conditioning before allogeneic stem cell transplantation (Q58814237) (← links)
• Feasibility of NIH consensus criteria for chronic graft-versus-host disease (Q82180116) (← links)
• The NIH consensus criteria for chronic graft-versus-host disease: far more than just another classification (Q83182897) (← links)
• Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease (Q83661208) (← links)
• Comparison of characteristics and outcomes of late acute and NIH chronic GVHD between Japanese and white patients (Q90260314) (← links)